Simplify Asset Management Inc.
13F filer · CIK 0001846368Reported Jul 16, 2026
Net buyer this quarter
13F portfolio value$7.19BU.S. long equity reported on 13F
Positions12416 new · 21 closed
Net flow last quarter+$97MBuys minus sells
Top 10 positions weight3.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 16, 2026124 positions | |||||
| $38.7M | 0.54% | Not reported | Not reported | Q3 2024 | |
| $30.9M | 0.43% | 0.64% | Not reported | Q1 2023 | |
| $28.6M | 0.40% | Not reported | Not reported | Q2 2024 | |
| $24.7M | 0.34% | 1.52% | +72.1% | Q1 2023 | |
| $24.6M | 0.34% | 0.11% | +32.6% | Q4 2021 | |
| $24.2M | 0.34% | Not reported | +54.2% | Q2 2024 | |
| $18.5M | 0.26% | 0.00% | +120.0% | Q4 2021 | |
| $17.8M | 0.25% | 0.52% | +101.9% | Q4 2025 | |
| $17.6M | 0.25% | 0.00% | -11.9% | Q4 2021 | |
| $17.5M | 0.24% | 0.00% | +1355.1% | Q4 2021 | |
| $16.5M | 0.23% | 0.11% | +32.5% | Q4 2025 | |
| $16.2M | 0.23% | 0.00% | +32.6% | Q1 2022 | |
| $16.2M | 0.23% | 0.03% | -30.4% | Q3 2025 | |
| $15.5M | 0.22% | 0.69% | +15.8% | Q2 2025 | |
| $13.5M | 0.19% | 2.92% | +78.9% | Q2 2024 | |
| $12.4M | 0.17% | 5.90% | New | Q2 2026 | |
| $11.6M | 0.16% | 0.01% | +32.6% | Q4 2021 | |
| $11.3M | 0.16% | 0.09% | -37.5% | Q4 2023 | |
| $11.2M | 0.16% | 0.23% | -17.4% | Q4 2025 | |
| $10.5M | 0.15% | 0.04% | Not reported | Q1 2025 | |
| $10.3M | 0.14% | 0.01% | +32.6% | Q3 2022 | |
| $9.89M | 0.14% | 0.01% | Not reported | Q4 2021 | |
| $9.35M | 0.13% | 1.39% | +20.9% | Q1 2024 | |
| $8.16M | 0.11% | 0.01% | +32.6% | Q4 2021 | |
| $7.6M | 0.11% | 0.00% | +32.4% | Q1 2022 | |
| $7.35M | 0.10% | 0.01% | +31.6% | Q4 2021 | |
| $6.48M | 0.09% | Not reported | +32.4% | Q1 2025 | |
| $6.38M | 0.09% | 0.01% | Not reported | Q4 2024 | |
| $5.72M | 0.08% | 0.47% | +22.7% | Q1 2025 | |
| $5.19M | 0.07% | 0.20% | +14.2% | Q3 2022 | |
| $5.19M | 0.07% | 0.00% | +31.8% | Q4 2022 | |
| $4.49M | 0.06% | 2.69% | +122.3% | Q1 2025 | |
| $4.47M | 0.06% | 0.00% | -4.3% | Q4 2020 | |
| $4.39M | 0.06% | 0.45% | +26.4% | Q1 2025 | |
| $4.14M | 0.06% | 0.02% | +32.4% | Q2 2025 | |
| $3.86M | 0.05% | 0.07% | +22.3% | Q1 2024 | |
| $3.33M | 0.05% | 0.76% | +1.4% | Q4 2024 | |
| $3.33M | 0.05% | 0.01% | +32.6% | Q2 2025 | |
| $2.98M | 0.04% | 0.00% | -30.4% | Q4 2021 | |
| $2.7M | 0.04% | 0.31% | -5.0% | Q1 2023 | |
| $2.3M | 0.03% | 0.02% | -30.0% | Q1 2026 | |
| $2.13M | 0.03% | 0.60% | -32.0% | Q2 2024 | |
| $2.11M | 0.03% | 0.21% | +32.6% | Q4 2024 | |
| $1.99M | 0.03% | 0.00% | -14.9% | Q3 2022 | |
| $1.98M | 0.03% | 0.07% | -23.0% | Q3 2025 | |
| $1.91M | 0.03% | 0.00% | +18.8% | Q3 2025 | |
| $1.86M | 0.03% | 0.00% | +32.5% | Q4 2021 | |
| $1.76M | 0.02% | 0.06% | +64.9% | Q4 2025 | |
| $1.69M | 0.02% | 0.00% | +32.6% | Q4 2021 | |
| $1.63M | 0.02% | 0.30% | +5.5% | Q4 2025 | |
| Q1 2026Reported Apr 27, 2026129 positions | |||||
| $37.5M | 0.58% | Not reported | Not reported | Q3 2024 | |
| $30.9M | 0.47% | 0.64% | Not reported | Q1 2023 | |
| $26.9M | 0.41% | 0.05% | -12.0% | Q3 2025 | |
| $24.4M | 0.37% | Not reported | Not reported | Q2 2024 | |
| $20.3M | 0.31% | 0.08% | +43.7% | Q4 2021 | |
| $18.3M | 0.28% | 0.15% | -0.3% | Q4 2023 | |
| $15.4M | 0.24% | 0.00% | -40.3% | Q4 2021 | |
| $12M | 0.18% | Not reported | Not reported | Q2 2024 | |
| $10.6M | 0.16% | 0.00% | +104.5% | Q1 2022 | |
| $9.78M | 0.15% | 0.08% | -27.3% | Q4 2025 | |
| $9.19M | 0.14% | 0.98% | -8.4% | Q1 2023 | |
| $8.56M | 0.13% | 0.00% | +276.9% | Q4 2021 | |
| $8.55M | 0.13% | 0.00% | +63.7% | Q3 2022 | |
| $8.42M | 0.13% | 0.01% | -65.0% | Q2 2022 | |
| $8.1M | 0.12% | 0.00% | +50.8% | Q4 2021 | |
| $7.6M | 0.12% | 0.60% | -6.2% | Q2 2025 | |
| $7.53M | 0.12% | 0.28% | -27.0% | Q4 2025 | |
| $6.43M | 0.10% | 0.01% | +886.4% | Q1 2024 | |
| $6.13M | 0.09% | 0.26% | -27.4% | Q4 2025 | |
| $6.12M | 0.09% | 0.00% | -27.3% | Q4 2021 | |
| $5.99M | 0.09% | 1.64% | +271.9% | Q2 2024 | |
| $5.57M | 0.09% | 0.00% | -69.7% | Q1 2022 | |
| $5.09M | 0.08% | Not reported | -27.3% | Q1 2025 | |
| $4.96M | 0.08% | 0.00% | -27.0% | Q4 2021 | |
| $4.2M | 0.06% | 0.39% | -13.1% | Q1 2025 | |
| $4.12M | 0.06% | 0.00% | -13.6% | Q4 2020 | |
| $4.01M | 0.06% | 0.35% | +8.4% | Q1 2025 | |
| $3.88M | 0.06% | 0.00% | -27.1% | Q4 2021 | |
| $3.54M | 0.05% | 0.00% | -54.6% | Q4 2022 | |
| $3.48M | 0.05% | 2.22% | Not reported | Q1 2024 | |
| $3.4M | 0.05% | 0.09% | -26.6% | Q4 2024 | |
| $3.19M | 0.05% | 0.06% | +188.7% | Q1 2024 | |
| $3.01M | 0.05% | 0.18% | -27.3% | Q3 2022 | |
| $2.92M | 0.04% | 0.33% | -18.5% | Q1 2023 | |
| $2.79M | 0.04% | 0.01% | -27.3% | Q2 2025 | |
| $2.42M | 0.04% | 0.76% | Not reported | Q4 2024 | |
| $2.28M | 0.03% | 0.89% | +1.5% | Q2 2024 | |
| $2.19M | 0.03% | 0.10% | -18.8% | Q3 2025 | |
| $2M | 0.03% | 0.21% | +3.2% | Q4 2025 | |
| $1.92M | 0.03% | 0.02% | -29.6% | Q2 2025 | |
| $1.79M | 0.03% | 1.28% | Not reported | Q1 2025 | |
| $1.77M | 0.03% | Not reported | -32.5% | Q4 2025 | |
| $1.77M | 0.03% | 0.00% | -8.2% | Q3 2025 | |
| $1.76M | 0.03% | 0.01% | -70.8% | Q2 2024 | |
| $1.71M | 0.03% | 0.00% | +20.2% | Q3 2021 | |
| $1.59M | 0.02% | 0.00% | -27.3% | Q4 2021 | |
| $1.54M | 0.02% | 0.00% | -2.5% | Q3 2022 | |
| $1.53M | 0.02% | 1.59% | Not reported | Q3 2025 | |
| $1.52M | 0.02% | 0.04% | New | Q1 2026 | |
| $1.49M | 0.02% | 0.29% | -10.0% | Q4 2025 | |
| Q4 2025Reported Feb 9, 2026130 positions | |||||
| $39.5M | 0.64% | 0.06% | +25.0% | Q3 2025 | |
| $38.8M | 0.63% | Not reported | Not reported | Q3 2024 | |
| $32.9M | 0.54% | 0.01% | +239.9% | Q4 2021 | |
| $30.1M | 0.49% | 0.00% | +189.5% | Q4 2021 | |
| $26.7M | 0.44% | Not reported | Not reported | Q2 2024 | |
| $24.4M | 0.40% | 0.64% | Not reported | Q1 2023 | |
| $24M | 0.39% | 0.03% | +140.0% | Q2 2022 | |
| $17.1M | 0.28% | 0.01% | Not reported | Q1 2022 | |
| $16.7M | 0.27% | 0.15% | Not reported | Q4 2023 | |
| $16.6M | 0.27% | 1.07% | +227.4% | Q1 2023 | |
| APAPLSApellis Pharmaceuticals, Inc. | $13.5M | 0.22% | 0.42% | +403.3% | Q3 2025 |
| $12.1M | 0.20% | 0.12% | New | Q4 2025 | |
| $11.6M | 0.19% | 0.05% | +19.7% | Q4 2021 | |
| $10.8M | 0.18% | 0.72% | +773.6% | Q2 2025 | |
| $10.2M | 0.17% | 0.01% | +449.8% | Q4 2021 | |
| $8.72M | 0.14% | 0.35% | New | Q4 2025 | |
| $8.35M | 0.14% | 0.00% | +92.9% | Q4 2021 | |
| $7.93M | 0.13% | 0.01% | +1327.9% | Q4 2022 | |
| $7.93M | 0.13% | 0.38% | New | Q4 2025 | |
| $6.86M | 0.11% | 0.45% | +314.9% | Q1 2025 | |
| $6.53M | 0.11% | Not reported | +92.1% | Q1 2025 | |
| $6.42M | 0.10% | 0.02% | +87.6% | Q2 2024 | |
| $5.89M | 0.10% | 2.23% | Not reported | Q1 2024 | |
| $5.88M | 0.10% | 0.01% | -12.7% | Q4 2021 | |
| $5.78M | 0.09% | 0.00% | -47.3% | Q4 2020 | |
| $5.43M | 0.09% | 0.00% | -35.5% | Q1 2022 | |
| $5.34M | 0.09% | 0.45% | Not reported | Q1 2023 | |
| $5.31M | 0.09% | 0.25% | +92.1% | Q3 2022 | |
| $5.19M | 0.08% | 0.13% | +92.0% | Q4 2024 | |
| $4.92M | 0.08% | 0.04% | +89.7% | Q2 2023 | |
| $4.77M | 0.08% | 0.30% | -17.9% | Q1 2025 | |
| $4.6M | 0.08% | 0.00% | -37.7% | Q3 2022 | |
| $4.54M | 0.07% | 0.00% | +92.6% | Q4 2021 | |
| $4.43M | 0.07% | 0.01% | +91.7% | Q2 2025 | |
| $4.14M | 0.07% | 0.14% | -47.8% | Q3 2025 | |
| $3.93M | 0.06% | 0.01% | +92.6% | Q4 2021 | |
| $3.22M | 0.05% | 0.10% | +107.1% | Q3 2025 | |
| $3.04M | 0.05% | 1.42% | -46.8% | Q1 2025 | |
| $3.02M | 0.05% | 0.02% | -4.9% | Q2 2025 | |
| $2.95M | 0.05% | Not reported | New | Q4 2025 | |
| $2.68M | 0.04% | 0.00% | +89.7% | Q4 2021 | |
| $2.67M | 0.04% | 0.00% | +91.5% | Q4 2021 | |
| $2.64M | 0.04% | 0.75% | Not reported | Q4 2024 | |
| $2.64M | 0.04% | 0.91% | -11.5% | Q2 2024 | |
| $2.62M | 0.04% | 0.01% | +87.8% | Q2 2023 | |
| $2.5M | 0.04% | 0.03% | +72.9% | Q3 2025 | |
| $2.31M | 0.04% | 0.13% | Not reported | Q3 2025 | |
| $2.29M | 0.04% | 0.02% | -72.4% | Q3 2025 | |
| $2.23M | 0.04% | 0.21% | +91.9% | Q4 2024 | |
| $2.17M | 0.04% | 2.23% | +91.9% | Q1 2024 | |
| Q3 2025Reported Oct 20, 2025113 positions | |||||
| $41.3M | 0.76% | 0.05% | New | Q3 2025 | |
| $39.2M | 0.72% | Not reported | -42.8% | Q3 2024 | |
| $26.9M | 0.49% | Not reported | +3587.0% | Q2 2024 | |
| $23.2M | 0.43% | 0.64% | Not reported | Q1 2023 | |
| $10.8M | 0.20% | 0.00% | +0.9% | Q4 2020 | |
| $10.1M | 0.19% | 0.00% | +624.8% | Q4 2021 | |
| $8.54M | 0.16% | 0.00% | +100.6% | Q1 2022 | |
| $8.35M | 0.15% | 0.05% | Not reported | Q4 2021 | |
| $8.29M | 0.15% | 0.28% | New | Q3 2025 | |
| $7.77M | 0.14% | 0.33% | +13.8% | Q1 2023 | |
| $7.61M | 0.14% | 0.37% | -5.5% | Q1 2025 | |
| $7.37M | 0.14% | 0.00% | -31.5% | Q4 2021 | |
| $7.3M | 0.13% | 0.01% | +251.1% | Q2 2022 | |
| ATAKROAkero Therapeutics, Inc. | $6.91M | 0.13% | 0.18% | Not reported | Q1 2023 |
| $6.68M | 0.12% | 0.00% | +13.8% | Q3 2022 | |
| $6.4M | 0.12% | 0.01% | +80.8% | Q4 2021 | |
| $5.99M | 0.11% | 0.26% | -22.3% | Q4 2024 | |
| $5.77M | 0.11% | 0.25% | -29.7% | Q2 2025 | |
| $5.67M | 0.10% | 3.33% | +186.2% | Q1 2025 | |
| $5.22M | 0.10% | 0.10% | New | Q3 2025 | |
| $5.14M | 0.09% | 0.04% | -21.2% | Q2 2024 | |
| $4.96M | 0.09% | 0.44% | +67.7% | Q2 2025 | |
| $3.79M | 0.07% | 0.45% | -38.3% | Q1 2023 | |
| $3.73M | 0.07% | 2.24% | Not reported | Q1 2024 | |
| $3.42M | 0.06% | 0.00% | -12.2% | Q4 2021 | |
| MMRUSMerus N.V. | $3.14M | 0.06% | 0.04% | New | Q3 2025 |
| $2.98M | 0.05% | 1.08% | +1.2% | Q2 2024 | |
| $2.83M | 0.05% | Not reported | +13.9% | Q1 2025 | |
| $2.83M | 0.05% | 0.01% | +26.6% | Q2 2024 | |
| $2.81M | 0.05% | 0.74% | +144.9% | Q4 2024 | |
| ATAPLTApplied Therapeutics, Inc. | $2.71M | 0.05% | 3.11% | Not reported | Q1 2023 |
| APAPLSApellis Pharmaceuticals, Inc. | $2.42M | 0.04% | 0.08% | New | Q3 2025 |
| $2.39M | 0.04% | 0.07% | +13.8% | Q4 2024 | |
| $2.31M | 0.04% | 0.00% | -15.4% | Q2 2025 | |
| $2.2M | 0.04% | 0.13% | New | Q3 2025 | |
| $2.12M | 0.04% | 0.01% | +13.8% | Q2 2025 | |
| $2.11M | 0.04% | 0.00% | +14.0% | Q4 2021 | |
| $2.11M | 0.04% | 0.02% | Not reported | Q2 2023 | |
| $1.94M | 0.04% | 0.02% | +16.8% | Q2 2025 | |
| $1.91M | 0.04% | 0.01% | -47.4% | Q4 2024 | |
| $1.72M | 0.03% | 0.01% | +13.9% | Q4 2021 | |
| $1.68M | 0.03% | 0.05% | -72.4% | Q2 2025 | |
| $1.66M | 0.03% | 0.30% | Not reported | Q4 2024 | |
| $1.65M | 0.03% | 3.77% | -13.6% | Q1 2023 | |
| $1.65M | 0.03% | 0.10% | +13.8% | Q2 2025 | |
| $1.6M | 0.03% | 0.00% | -55.7% | Q4 2021 | |
| $1.58M | 0.03% | 0.03% | Not reported | Q1 2024 | |
| $1.56M | 0.03% | 0.13% | Not reported | Q3 2022 | |
| $1.54M | 0.03% | 0.00% | Not reported | Q3 2021 | |
| $1.5M | 0.03% | 0.02% | New | Q3 2025 | |
Premium opens every quarter this fund has filed